FTAI Aviation (FTAI) closed the last trading session at $123.35, gaining 14.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $171 indicates a 38.6% upside potential.The average comprises 12 short-term price targets ranging from a low of $123 to a high of $300, with a standard deviation of $46.90. While the lowest estimate indicates a decline of 0.3% from the current price level, ...

Shares of Agenus (AGEN) have gained 68.4% over the past four weeks to close the last trading session at $5, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $6.33 indicates a potential upside of 26.6%.The mean estimate comprises three short-term price targets with a standard deviation of $2.08. While the lowest estimate of $4 indicates a 20% decline from the current price level, ...

I’m pleased to report that Clean Harbors (NYSE: CLH ) has followed through exactly as I predicted in my bullish thesis earlier this year. Since my March publication , the stock has climbed up aroundI am a financial analyst and writer with a strong foundation in financial modeling, valuation, and data analysis. I hold FMVA (Financial Modeling & Valuation Analyst) and BIDA (Business Intelligence & Data Analyst) certifications from the Corporate Finance Institute (CFI) in Canada.The markets fascinate me (we're ...

Amneal Pharmaceuticals (AMRX) closed the last trading session at $7.45, gaining 3.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $11.50 indicates a 54.4% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $0.58. While the lowest estimate of $11 indicates a 47.7% increase from the current price level, the most optimistic analy ...

Rambus (RMBS) closed the last trading session at $56.30, gaining 12.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $72.25 indicates a 28.3% upside potential.The mean estimate comprises eight short-term price targets with a standard deviation of $9.97. While the lowest estimate of $55 indicates a 2.3% decline from the current price level, the most optimistic analyst expects the ...

Core Viewpoint - Zymeworks Inc. (ZYME) shows potential for significant upside, with a mean price target of $21.35 indicating a 76.7% increase from its current price of $12.08 [1] Price Targets and Estimates - The mean estimate consists of 10 short-term price targets with a standard deviation of $7.45, indicating variability among analysts [2] - The lowest estimate is $12, suggesting a slight decline of 0.7%, while the highest estimate predicts a surge of 148.3% to $30 [2] - Analysts' price targets are often questioned for their reliability, as they may mislead investors rather than provide accurate guidance [3][7] Earnings Estimates and Analyst Agreement - Analysts are optimistic about ZYME's earnings, with a consensus indicating better-than-previously estimated earnings [4] - The Zacks Consensus Estimate for the current year has risen by 6.2% over the past month, with four estimates increasing and no negative revisions [12] - A strong correlation exists between earnings estimate revisions and near-term stock price movements, suggesting potential upside for ZYME [11] Zacks Rank and Investment Potential - ZYME holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors [13] - While the consensus price target may not be a reliable indicator of the stock's potential gain, it does provide a directional guide for price movement [13]

Energy Transfer LP (ET) closed the last trading session at $17.90, gaining 13.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $22.93 indicates a 28.1% upside potential.The average comprises 14 short-term price targets ranging from a low of $19 to a high of $26, with a standard deviation of $1.94. While the lowest estimate indicates an increase of 6.2% from the current price leve ...

Shares of Knot Offshore (KNOP) have gained 0.3% over the past four weeks to close the last trading session at $6.39, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $13.17 indicates a potential upside of 106.1%.The average comprises three short-term price targets ranging from a low of $12 to a high of $15, with a standard deviation of $1.61. While the lowest estimate indicates a ...

Shares of Intellia Therapeutics, Inc. (NTLA) have gained 6.1% over the past four weeks to close the last trading session at $7.69, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $38.32 indicates a potential upside of 398.3%.The average comprises 25 short-term price targets ranging from a low of $7 to a high of $106, with a standard deviation of $24.94. While the lowest estimate ...

Shares of HNI (HNI) have gained 8.8% over the past four weeks to close the last trading session at $47.26, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $69.50 indicates a potential upside of 47.1%.The average comprises four short-term price targets ranging from a low of $63 to a high of $80, with a standard deviation of $7.59. While the lowest estimate indicates an increase o ...